Abstract:Objective To study C-X3-C chemokine ligand 1 (CX3CL1) in plasma or cerebrospinal fluid whether could be used as an biomaker of central nervous system infection.Methods The plasma and CSF samples were collected from neonates who were suspected to have central nervous infection with lumbar puncture check admitted to Neonatal Ward of Children's Hospital of Fudan University from December 2015 to May 2016,and they set for infection group,according to clinical manifestations,cerebrospinal fluid routine,biochemistry and culture results,they were divided into the central infection,sepsis and non-sepsis groups.At the same period healthy newborns cord blood samples were collected in the maternity ward of Obstetrics and Gynecology Hospital of Fudan University as a normal control group,and on the basis of birth weight group was divided into ＜ 2 000 g,-2 500 g,-3 000 g,-3 500 g,＞3 500 g groups;and according to gestational age divided into ＜ 33 w,-35 w,-37 w,-39 w,＞39 w groups.Using Luminex technology to detect CX3CL1 protein levels (Milliplex reagent kit HCYTOMAG-60K-06),the differences between groups and subgroups were compared.Results In 69 cases of control group,there were 24 cases wit hinfection.There were 8 cases in central infection group (meningitis),10 cases in sepsis group and 6 cases in non-sepsis subgroup (1 case with urinary tract infection,2 cases with neonatal convulsion,1 case with hyperbilirubinemia and esophageal tracheal fistula).In the control group,CX3CL1 in cord blood was (97.8+.13.3) pg · mL-1,there was no significant difference in cord blood CX3CL1 level among different body weight subgroups and different gestational weeks subgroups (P＞0.05).In infection group plasma CX3CL1 level [(95.1±8.2)pg · mL-1] had no significant difference from control group(t=-1.045,P=0.299).There was significant difference in CX3CL1 level between plasma and cerebrospinal fluid,CX3CL1 level was significantly higher in cerebrospinal fluid(210.0 ± 11.9) pg · mL-1 (P ＜ 0.001).Among central infection group,sepsis group and non-sepsis group cerebrospinal fluid CX3CL1 levels (243.1 ± 13.3) pg · mL-1,(208.2 ± 20.1) pg · mL-1 and (168.7 ± 20.6) pg · mL-1,there were significant differences (P=0.046);There were also significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and non-sepsis group (P =0.016);There were no significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and sepsis group (P =0.180) or between sepsis group and non-sepsis group (P =0.169).Conclus1on CX3CL1 level in plasma is relatively stable in the healthy newborns,CX3CL1 level in plasma can not be used to diagnose central nervous infection,CSF CX3CL1 levels may be an auxiliary biomarker for diagnosis of central nervous infection and its severity.

Expression and clinical significance of NSE and IGF-Ⅰ in cerebrospinal fluid of pediatric patients with central system infections

Differential Diagnostic Significance of Cytokines in Cerebrospinal Fluid of Children with Acute Central Nervous System Infections

Clinical Significance of Neuron Specific Enolase and S100 Beta Protein in Intracranial Infection and Brain Injury.

Clinical characteristic analysis for invasive fungal infection in neonatal intensive care unit

Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a retrospective study of 90 patients

Expression Level of NSE, S100B and NPY in Children with Acute Miliary Phthisis and Secondary Tubercular Meningitis.

Cerebrospinal Fluid Chemokine Patterns in Children with Enterovirus 71-Related Encephalitis

Analysis of immune indexs in cerebrospinal fluid with infection diseases of central nervous system

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

Clinical application and evaluation of metagenomic next-generation sequencing in pathogen detection for suspected central nervous system infections

Study on the correlation between CX3CL1 and neonatal central nervous system infection

Elevated levels of β2-microglobulin in cerebrospinal fluid in adult patients with viral encephalitis/meningitis

Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Unexplained Central Nervous System Infections

Comparison of the Diagnostic Efficacy of SAA1, HBP, CRP，PCT and Cytokine Profiles for Predicting Infection in Pediatric Febrile Patients

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Discriminating Infectious Meningitis Versus Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: a Single-Center Experience

Cerebrospinal Fluid Th1/Th2 Cytokine Profiles in Children with Enterovirus 71-Associated Meningoencephalitis.

Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection

Metagenomic next-generation sequencing of cerebrospinal fluid reveals etiological and microbiological features in patients with various central nervous system infections

Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders

Cerebrospinal Fluid Neuron Specific Enolase, Interleukin-1Β and Erythropoietin Concentrations in Children after Seizures